maslinic acid has been researched along with Bone Loss, Osteoclastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, XL; Liu, M; Liu, T; Luo, J; Qiu, WW; Wei, G; Wu, Y | 1 |
Li, C; Li, D; Li, H; Li, Z; Liu, M; Luo, J; Ma, Y; Qian, M; Qiu, W; Tang, J; Wang, P; Wang, X; Wu, X; Yang, Z; Zhang, L; Zheng, C | 1 |
2 other study(ies) available for maslinic acid and Bone Loss, Osteoclastic
Article | Year |
---|---|
Synthesis of heterocyclic ring-fused tricyclic diterpene analogs as novel inhibitors of RANKL-induced osteoclastogenesis and bone resorption.
Topics: Animals; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Diterpenes; Dose-Response Relationship, Drug; Female; Heterocyclic Compounds; Mice; Mice, Inbred C57BL; Molecular Structure; Osteogenesis; RANK Ligand; Structure-Activity Relationship | 2017 |
Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Topics: Actins; Animals; Biomarkers; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Cell Line; Female; Gene Expression Regulation; Macrophage Colony-Stimulating Factor; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Monocytes; NF-kappa B; NFATC Transcription Factors; Osteoblasts; Osteoclasts; Osteogenesis; Ovariectomy; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; TNF Receptor-Associated Factor 6; Transcription Factor AP-1; Triterpenes | 2011 |